Pancreatic and Biliary Stents Market Trends

Statistics for the 2023 & 2024 Pancreatic and Biliary Stents market trends, created by Mordor Intelligence™ Industry Reports. Pancreatic and Biliary Stents trend report includes a market forecast to 2029 and historical overview. Get a sample of this industry trends analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Trends of Pancreatic and Biliary Stents Industry

This section covers the major market trends shaping the Pancreatic & Biliary Stents Market according to our research experts:

Metal Pancreatic and Biliary Stents is Expected to Witness a Significant Growth Over the Forecast Period.

Metal stents are self-expandable mesh-like tubes of thin wire which are inserted into a lumen or duct in the human body to maintain the passage open in the bile or pancreatic duct. The segment is expected to witness significant growth owing to the wide application of a range of metal stents for the treatment of various pancreatic and biliary-related diseases such as pancreatic cancer, pancreatic and biliary leaks, and other malignant obstructions. Moreover, the increase in the number of prostate cancers worldwide has significantly aided in the growth of metallic stents. For instance, in 2022 ACS, reported a 12.5% increase in prostate cancer cases in the US over the last three years reaching 268.5 thousand prostate cancer cases in 2022. Thus, the high number of prostate cancer cases is driving the demand for metallic stents for its treatment thereby driving the growth of this segment.

The increasing research and clinical studies related to applications of metallic stents are also propelling the growth of this segment. For instance, an article published by the journal Scientific Reports, in May 2022, stated that a clinical study reported the successful treatment of benign biliary structures (BBS) using fully covered self-expandable metal stents. Thus, such promising results are leading to the increasing demand for metallic stents thereby driving the growth of the segment.

Furthermore, new products and the development of better technology have bolstered the pancreatic and biliary market. For instance, in May 2021, AMG International GmbH launched the CE mark approval of their second fully biodegradable metal stent UNITY-B, which is a balloon expandable biodegradable biliary stent (BEBS) for endoscopic use. This product launch was aimed at expanding the company's product offering as well as enhancing its market presence.

Thereby, the sector is anticipated to experience significant expansion, thus driving the market throughout the forecast period, thanks to the widespread application of a variety of metal stents for the treatment of various pancreatic and biliary-related illnesses.

Pancreatic and Biliary Stents Market : Increasing Prevalence of Pancreatic Cancer Cases (In Thousands), Global, By Year,2025-2040

North America Region is Expected to Witness a Significant Growth Over the Forecast Period.

North America is expected to witness significant growth owing to the well-established healthcare industry and the rising prevalence of chronic diseases like prostate cancer, pancreatic cancer, and gall bladder cancer which is increasing the demand for pancreatic and biliary stents. For instance, ACS in 2022, reported 32.9 thousand new pancreatic cancer cases in men compared to 29.2 thousand pancreatic cancer cases in women in the United States. Similarly, CAGS in January 2022, reported the high prevalence of gallbladder cancer in Canada. As a result, the rising prevalence of pancreatic and gallbladder cancers in North American countries is fueling the expansion of the examined market for pancreatic stents.

Furthermore, the recent mergers, acquisitions, and partnerships are further driving the growth of this segment. For instance, in May 2021, Cook Medical acquired Cantel Medical to expand its biliary stent and another product portfolio to provide services to customers globally. Thus, such development in the region is likely to boost the demand for pancreatic and biliary stents. Similarly, in July 2022, CDC reported that in 2021, 4.5 million adults were diagnosed with chronic liver disease in the United States alone which contributed to 1.8% of the country's total adult population diagnosed with the disease. When liver inflammation results in bile duct blockage, a biliary stent must be implanted to relieve the obstruction. This drives up demand for biliary stents and contributes to the growth of the studied market in the region.

Thus, the region is likely to have considerable growth, boosting the market throughout the forecast period, on account of its well-established healthcare industry and the rising prevalence of chronic diseases such as prostate cancer, pancreatic cancer, and gall bladder cancer.

Pancreatic and Biliary Stents Market - Growth by Region

Pancreatic and Biliary Stents Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)